Cardiovascular system

Published on 03/06/2015 by admin

Filed under Neonatal - Perinatal Medicine

Last modified 03/06/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2585 times

Cardiovascular system

The circulatory system is the transport system that supplies body cells with substrates absorbed from the gastrointestinal tract and oxygen from the lungs and returns carbon dioxide to the lungs for disposal; other by-products of metabolism are routed to the kidneys for elimination. The cardiovascular system (CVS) is also involved in the regulation of body temperature and the distribution of hormones and other substances that regulate cellular functioning.

During pregnancy the maternal cardiovascular system must meet the demands of both the mother and the dynamically changing fetus. The constant ebb and flow of nutrients and by-products via the uteroplacental system creates a sensitive interdependence between the mother and the fetus. At birth the infant undergoes significant changes in the CVS that may, if altered, compromise extrauterine existence and postnatal adaptation. This chapter examines alterations in the CVS during the perinatal period and implications for the mother, fetus, and neonate.

Maternal physiologic adaptations

Pregnancy is associated with physiologically significant but reversible changes in maternal hemodynamics and cardiac function. These changes are mediated by increased levels of circulating estrogens; progesterone; prostaglandins (PG), especially PGE1 and PGE2; and other vasoactive substances, as well as by the increased load on the cardiovascular system. The increased circulating maternal blood mass, fetal nutritional requirements, and placental circulatory system place increased demands on the maternal cardiovascular system. In most women these demands are met without compromising the mother. However, when superimposed upon an existing disease state, in which hemodynamics are already compromised, pregnancy may prove to be a dangerous situation for maternal homeostasis.

Conversely, if maternal hemodynamics do not change, adverse effects on the uteroplacental circulation can lead to fetal compromise, which may be manifested as fetal malformations (including congenital heart disease), fetal growth restriction, or pregnancy loss. Therefore the maternal cardiovascular system must achieve a balance between fetal needs and maternal tolerance.

The maternal cardiovascular system is further altered during the intrapartum period. During the second stage of labor, expulsive efforts lead to an increase in muscle tension and intrathoracic and intraabdominal pressure, all of which affect the functioning of the heart and the hemodynamics of the maternal system. Intraabdominal pressure is abruptly decreased upon delivery and blood pools in the abdominal organs, thereby affecting cardiac return. Blood loss during delivery may also affect hemodynamics.

Antepartum period

The major hemodynamic changes that occur during pregnancy are outlined in Table 9-1. These changes begin as early as 4 to 5 weeks of gestation and tend to plateau during the second or early third trimester.48 Cardiovascular and hemodynamic changes are due to hormonal influences, changes in other organ systems, and mechanical forces. The hemodynamic changes are partly the result of hormonal influences as well as of the development of the placental circulation and alterations in systemic vascular resistance (SVR). These changes include increases in total blood volume, plasma volume, red blood cell (RBC) volume, and cardiac output. Anatomic changes, such as the upward displacement of the diaphragm by the gravid uterus, shift the heart upward and laterally. There is slight cardiac enlargement on radiograph, and the left heart border is straightened. The size and position of the uterus, the strength of the abdominal muscles, and the configuration of the abdomen and thorax determine the extent of these changes.34

Table 9-1

Physiologic Changes of Pregnancy on the Cardiovascular System

PARAMETER MODIFICATION MAGNITUDE TIME OF PEAK INCREASE OR DECREASE
Oxygen consumption (VO2) Increase +20% to 30% Term
Blood volume:      
Plasma Increase +40% to 60% (usually 45% to 50%) 32 weeks
Red blood cells Increase +20% to 30% 30 to 32 weeks
Total body water Increase +6 to 8 L Term
Resistance changes:      
Systemic circulation Decrease –20% to 30% 16 to 34 weeks
Pulmonary circulation Decrease –30% 34 weeks
Blood pressure (SVR X CO):*      
Systolic Slight or no decrease    
Diastolic Decrease 10 to 15 mmHg 24 to 32 weeks
    (1.33 to 1.99 kPa)  
Myocardial contractility:      
Chronotropism (HR) Increase +0% to 20% 28 to 32 weeks
Inotropism (SV) Increase +25% to 30% 16 to 24 weeks
Cardiac output (HR X SV)* Increase +30% to 50% 28 to 32 weeks
Uteroplacental circulation Increase Greater than 1000% Term

image

CO, Cardiac output; HR, heart rate; SV, stroke volume, SVR, systemic vascular resistance.

*Position dependent.

Adapted from Gei, A.F. & Hankins, G.D. (2001). Cardiac disease and pregnancy. Obstet Gynecol Clin North Am, 28, 469.

Hemodynamic changes

Hemodynamic alterations in pregnancy include changes in blood volume, cardiac output, heart rate, systemic blood pressure, vascular resistance, and distribution of blood flow. Stroke volume, heart rate, and cardiac output increase significantly, whereas SVR, pulmonary vascular resistance (PVR), and colloid osmotic pressure decrease. Changes in blood, plasma, and RBC volume are discussed further in  Chapter 8.

Total blood volume.

Total blood volume (TBV) is a combination of plasma volume and RBC volume, each of which increases during pregnancy. Circulating blood volume increases begin by at least 6 weeks’ gestation.111 Circulating blood volume increases by 30% to 40% (approximately 1½ L), with a usual range of 30% to 45%.40,111,115 TBV increases rapidly until midpregnancy and then more slowly during the latter half, peaking at 28 to 34 weeks, then plateaus or decreases slightly to term.27,81,111,135 Changes in blood volume are due to the increased steroid hormones, plasma renin activity, aldosterone, human placental lactogen, atrial natriuretic factor, and other mediators.18,48 Figure 8-1 illustrates changes in total blood volume and its component parts, plasma volume, and RBC volume.

The rise in blood volume correlates directly with fetal weight, supporting the concept of the placenta as an arteriovenous shunt in the maternal vascular compartment. Although the degree of hypervolemia varies from woman to woman, subsequent pregnancies in the same woman result in similar increases in circulating volume. Twin and other multiple pregnancies, however, result in greater increases in blood volume, imposing substantially greater demands on the cardiovascular system.111,135

Plasma volume.

About 75% of the TBV increase is in plasma volume. Plasma volume increases progressively from 6 to 8 weeks by approximately 45% to 50% (range, 40% to 60%) or about 1200 to 1600 mL above nonpregnant values 27,111 This change begins at 6 to 8 weeks and increases rapidly during the second trimester, followed by a slower but progressive increase that reaches its maximum of 4700 to 5200 mL at about 32 weeks.22,81,111 Alterations in blood and plasma volume are influenced by hormonal effects, nitric oxide mediated vasodilation, mechanical factors (blood flow in uteroplacental vessels) (see Chapter 8), and changes in the renal system and in fluid and electrolyte homeostasis (see Chapter 11).

Nitric oxide mediated vasodilation induces changes in the renin-angiotensin-aldosterone system, with increased sodium and water retention (see Chapter 11).111 Plasma renin activity and blood aldosterone levels are increased due to the action of estrogens, progesterone, and prostaglandins. An increase in plasma renin activity enhances sodium retention, thereby stimulating aldosterone secretion. Progesterone inhibits the action of aldosterone on the renal tubular cells, thus contributing to sodium retention and an increase in total body water. The degree of fluid retention is influenced by the increased distensibility of the vascular system and the uterine vein capacity present during pregnancy.27

Fluid distribution changes depending on body position. For example, the standing position or prolonged sitting is associated with the development of dependent edema. This is probably due to the trapping of blood in the legs and pelvis as the gravid uterus creates a mechanical impedance to blood flow through the inferior vena cava. This causes an increase in venous pressure in the lower extremities and a sharp rise in hydrostatic pressure in the microcirculation, with subsequent leakage of fluid from the vascular bed into the interstitium. The result is edema of the feet and ankles. Venous distensibility contributes to the decreased venous return to the heart.112

Red blood cell volume.

Red blood cell (RBC) production and thus volume increases throughout pregnancy to a level 20% to 30% higher than nonpregnant values.27,111 Intravascular expansion is mainly due to an increase in plasma volume; therefore hemodilution occurs. This physiologic anemia of pregnancy is reflected in a lower hematocrit and hemoglobin. These changes cannot be prevented with iron supplementation; however, women who are provided exogenous sources of iron do have higher hemoglobin levels in the third trimester than women not receiving supplements (see Figure 8-2). Changes in RBC volume are due to increased circulating erythropoietin and accelerated RBC production. The rise in erythropoietin in the last two trimesters is stimulated by progesterone, prolactin, and human placental lactogen.111 Changes in RBC volume and the role of iron are described further in Chapter 8.

Cardiac output and stroke volume.

Cardiac output, which is the product of heart rate times stroke volume, is one of the most significant hemodynamic changes encountered during pregnancy. Fifty percent of the increase occurs by 8 weeks’ gestation, mediated by changes in SVR.22,111 Cardiac output continues to rise more slowly until the third trimester to values, as measured in the left lateral recumbent position, 30% to 50% (usually 40% to 45%) greater than in nonpregnant women.1,18,25,27,111,115 A slight decline in cardiac output may be seen in late pregnancy due to the decrease in stroke volume near term.111 The increase in cardiac output is associated with an increase in venous return and greater right ventricular (RV) output, especially in the left lateral position.158

The increased cardiac output is due to changes in both stroke volume and heart rate. Changes in heart rate and stroke volume are reported by 5 weeks’ and 8 weeks’ gestation, respectively.111 The rise in cardiac output early in pregnancy is due primarily to an increase in stroke volume.1,60,111 Stroke volume increases progressively during the first and second trimesters, to a peak value of approximately 25% to 30% above nonpregnant values, peaking at 16 to 24 weeks.27,110 Stroke volume declines during the latter stages of pregnancy, and returns to values that are within the prepregnant range by term.22,27,111,158,162 The changes in stroke volume are likely due to increased ventricular muscle mass and end-diastolic volume changes.111 As pregnancy advances, the heart rate (see section on Heart Rate), which increases more slowly, becomes a more dominant factor in determining cardiac output.111 Figure 9-1 compares the changes in heart rate and stroke volume over gestation.

During pregnancy (especially the third trimester), the resting cardiac output fluctuates markedly with changes in body position.110,111,160 For example, a change from the left lateral recumbent position to supine can lead to a 25% to 30% decrease in cardiac output.160,162 Compression of the inferior vena cava by the uterus in the third trimester results in decreased venous return, stroke volume, and cardiac output.111 Heart rate changes do not necessarily occur with positional changes; therefore these changes in cardiac output are more likely due to a decrease in stroke volume.111,160

Twin, triplet, and other multiple pregnancies have a greater increase in cardiac output than do singleton pregnancies, possibly due to an increase in inotropy.78 The peak is greater, and the decline in cardiac output seen in late pregnancy is smaller. The cardiac output in multiple pregnancies is higher than that encountered in a singleton pregnancy by 20 weeks’ gestation and remains higher for the remainder of gestation.78,122

The increase in cardiac output during pregnancy is not related to the metabolic requirements of the mother or the fetus, or to the increase in maternal body mass. At the time the increase in cardiac output occurs, the fetus is relatively small. When fetal growth is accelerated (late in gestation), there is an actual decline in maternal cardiac output. There is, however, a progressive increase in maternal oxygen consumption, which may be due to the rising metabolic needs of the fetus as well as the demands of the maternal heart and respiratory muscles. Pregnancy at high altitudes is associated with less of an increase in cardiac output accompanied by a reduction in the usual expansion of maternal intravascular volume.79

The increased oxygen requirements are most likely the result of the contractility-promoting influences of estrogen and progesterone on heart and respiratory muscles and the development of the placental circulation. The placenta functions much like an arteriovenous shunt, with a concomitant decrease in peripheral vascular resistance. Therefore, despite the increase in cardiac output, there is a decrease in mean blood pressure due to a decrease in diastolic pressure. The concomitant increase in blood volume (either in time or magnitude) probably explains the increase in cardiac output. Both begin to rise as early as 6 to 8 weeks’ gestation, peaking toward the end of the second trimester, around 30% to 50% higher than prepregnant levels.110,111 

Changes in uterine blood flow might also contribute to the increased cardiac output. Progesterone, estrogens, and prolactin may cause changes in hemodynamics by directly affecting the myocardium. For example, estrogens may alter the actomyosin-adenosine triphosphatase (ATP) relationship in the myocardium, thereby increasing the contractility of the heart and altering the stroke volume. Similar effects can be seen with oral contraceptive use.

Heart rate.

Heart rate is the determinant of cardiac output that has the widest range of values. This wide range provides stability to the circulatory system under a variety of circumstances (e.g., from rest to maximal exercise). Heart rate can be altered in order to maintain blood pressure if changes in vascular resistance or stroke volume are encountered. However, an increased heart rate is insufficient to increase cardiac output; it must be accompanied by an increase in venous return. Both heart rate and venous return are increased in pregnancy, contributing to the increase in cardiac output seen throughout gestation.110,111 The increased heart rate compensates for the decreased SVR and is due to increased myocardial α receptors due to estrogen.25,68

The maternal heart rate increases progressively during pregnancy, averaging 10 to 20 beats per minute higher (10% to 20% increase) by 32 weeks (see Figure 9-1).18,27,65,68,111 At term, the heart rate may return to near baseline levels in some women. Twin pregnancies have an earlier acceleration in heart rate, with a maximum increase 40% above the nonpregnant level near term.34

The increased heart rate results in an elevated myocardial oxygen requirement, which is probably not important in women without cardiac disease, but may become significant in pregnant women with underlying cardiovascular pathology. Beyond this, the increased resting heart rate decreases the maximal work capacity by diminishing the output increment that can be achieved during maximal exercise.110

Blood pressure.

Although there are substantial increases in both blood volume and cardiac output during pregnancy, these changes are not associated with increases in either venous or arterial pressure since the increase in intravenous volume is balanced by the decreased SVR.18,111 In fact, blood pressure, especially diastolic pressure, is generally reported to decrease, reaching a nadir by midpregnancy.18,111 The initial decrease is thought to be due to a lag in compensation for changes in peripheral vascular resistance.111 The diastolic blood pressure decrease reaches a nadir at 24 to 32 weeks and then gradually returns to nonpregnant baseline values by term (Figure 9-2).23,27,111 The magnitude of blood pressure changes vary with the position of the woman during measurement. For example, arterial blood pressures are about 10 mmHg higher in sitting or standing than in a left lateral recumbent or supine position.111 Serial observations in a sitting or standing position show that as women advance through their pregnancies, systolic blood pressure remains either stable or decreases slightly, whereas diastolic pressure decreases an average of 10 to 15 mmHg (1.33 to 1.99 kPa).27,111 Mean arterial pressure decreases until midpregnancy, then increases to term.23 The reduction in blood pressure may be secondary to the vasodilatory effects of nitric oxide, which increases in pregnancy, as well as hormonal and other factors such as prostacyclin and relaxin that mediate a decrease in peripheral vascular resistance.123 Some investigators, have not found this midtrimester fall in blood pressure, but instead reported either no change or a slight rise from the first trimester until late pregnancy.116,151,165

Techniques and differences in the diastolic measurement point also influence blood pressure measurement. Therefore it is important to use a consistent method and maternal position to evaluate blood pressure.111,166 Conventional blood pressure techniques often lack standardization in terms of use of appropriate cuff size, equipment calibration, rounding off (to nearest 5 to 10 mmHg [0.66 to 1.33 kPa] versus the recommended 2 mmHg [0.26 kPa]), and method.57,66

Venous pressures during pregnancy also do not change significantly. Given the large increase in blood volume during pregnancy, an increase in venous pressure would be expected. The increased vascular capacitance and compliance seen during pregnancy explain this lack of change. These alterations are thought to be due to the effects of progesterone and endothelial-derived relaxant factors such as nitric oxide on blood vessel smooth muscle and collagen.4,111 Venous pressure below the uterus is increased, which may be caused by the increased capacitance encountered in the large pelvic veins and the veins distal to the uterus. The latter may affect venous return to the heart—especially in the upright position—due to regional pooling. The ability to sustain venous return is crucial in determining maternal exercise capacity (see “Exercise during Pregnancy”).110

Systemic vascular resistance.

Changes in cardiac output during pregnancy are accomplished without an increase in arterial pressures because of the marked decrease in SVR, especially in peripheral vessels (reduction in peripheral vascular resistance).24,158 SVR (mean arterial pressure divided by cardiac output) is decreased 20% to 30% during pregnancy and parallels the decrease in blood pressure.65 SVR decreases by 5 weeks and usually reaches its lowest level by 16 to 34 weeks, then progressively increases to term (Figure 9-3).22,111

The decreased vascular resistance is due to softening of collagen fibers and hypertrophy of smooth muscle, systemic vasodilation due to the vasodilatory effects of progesterone and prostaglandins, remodeling of the maternal spiral arteries (see Chapter 3), fluid retention (leading to blood volume expansion), and the addition of the low-resistance uteroplacental circulation, which receives a large proportion of cardiac output.26,48,111 The decline in resistance is not limited to the uteroplacental circulation; rather, it is seen throughout the body.90 The decreased SVR is also mediated by endothelial prostacyclin, and endothelial-derived relaxant factors (e.g., nitric oxide) that enhance vasodilation.24,48,65,111,144 Decreased systemic and renal vascular tone occur very early in pregnancy and precede changes in blood volume.24 Thus the decrease in SVR may be the stimulus for changes in heart rate and stroke volume, and thus cardiac output, in early pregnancy, as well as sodium and water retention (see Chapter 11), and alterations in blood pressure.24,25,48,111 The hormonal activity of pregnancy also has a role in the reduction of SVR and contributes to changes in regional blood flow. Along with this, the increased heat production (from maternal, fetal, and placental metabolism) stimulates vasodilation of vessels (especially in heat-losing areas such as the hands) and further reductions in resistance.

Regional blood flow.

Much of the increased maternal cardiac output is distributed to the uteroplacental circuit. The increase in cardiac output above the needs of the uteroplacental circulation leads to increased flow to other organ systems, particularly the mammary glands, skin, and kidneys. This creates a reservoir that can be tapped as pregnancy progresses. Blood flow to the splanchnic bed and skeletal muscle perfusion may decrease.68

Mammary blood flow is increased. Clinically increased flow is evident by the engorgement that occurs early in pregnancy and the dilation of veins on the surface of the breasts. This dilation is usually accompanied by a sensation of heat and tingling. The effect of pregnancy on coronary artery blood flow is unknown. With the increased workload of the left ventricle (LV) (because of the increased cardiac output, blood volume, fetal growth, uterus enlargement, and body weight gain), it can be assumed that the coronary blood flow is increased to meet the cardiac myometrial demands. Cerebral blood flow is not significantly altered during pregnancy.111,123 Although absolute blood flow to the liver does not change significantly, the percentage of the cardiac output perfusing the liver decreases.111

Uterine blood flow.

The decline in uterine vascular resistance allows blood flow to the uterus to increase during gestation. At 10 weeks’ gestation the blood flow is approximately 50 mL/min, increasing to 200 mL/min by 28 weeks and 500 to 800 mL/min at term.111,115 Thus by term the uterus is receiving between 10% and 20% of the maternal cardiac output, versus 2% in nonpregnant women.111 The uterine spiral arteries undergo marked changes during pregnancy (see Chapter 3) that disrupt their muscular and elastic elements. As a result, the uteroplacental arteries are almost completely dilated and are no longer responsive to circulating pressor agents or influences of the autonomic nervous system.136 This results in a large pool of blood within the uterus to maintain fetoplacental blood flow and oxygenation.

Renal blood flow.

Renal blood flow (RBF) increases by the end of the first trimester and then decreases to term (see Chapter 11). The percentage of the cardiac output perfusing the kidneys does not change and remains around 18%. The glomerular filtration rate (GFR) increases 40% to 50% over nonpregnant levels and is due in large part to the increased RBF. The decrease in renal vascular resistance may be mediated by nitric oxide, prostacyclin (PGI2), and atrial natriuretic factor.90

Skin perfusion.

Skin perfusion increases significantly during pregnancy, with a slow but steady rise in perfusion up to 18 to 20 weeks’ gestation. This slow rise is followed by a sharp increase between 20 and 30 weeks, with no significant increase after that. The increased flow is measurable for up to 1 week postpartum.90 Clinically this increased flow may be accompanied by an increase in skin temperature and clammy hands, which are the result of dermal capillary dilation. Vascular spiders and palmar erythema can be seen in many women during pregnancy (see Chapter 14). The vasodilation may facilitate the dissipation of excessive heat created by fetal metabolism. Increased peripheral flow can also be seen in the mucous membranes of the nasal passages, explaining the nasal congestion that is common in pregnancy (see  Chapter 15).90,123

Oxygen consumption

Oxygen consumption is a reflection of metabolic rate. During pregnancy there is a progressive increase in resting oxygen consumption, with a peak increase of 20% to 30% by term (Figure 9-4). This increase in oxygen consumption is due to the increased metabolic needs of the mother and the growing fetus.158 Oxygen consumption increases gradually over gestation, whereas cardiac output increases dramatically in the first and second trimesters. Because the resting cardiac output increases before there is a significant rise in maternal oxygen consumption, the arteriovenous oxygen difference decreases in early pregnancy, then gradually increases as oxygen consumption rises during pregnancy. This provides the uterus with well-oxygenated blood flow during the first trimester, before the completed development of the fetoplacental circulation.22,158

Physical changes

The physiologic hypervolemia of pregnancy results in alterations in the cardiac silhouette, chamber size, pressures, and electrocardiogram (ECG). These changes—along with the hemodynamic alterations—lead to changes in the physical findings encountered during cardiovascular assessment of the pregnant woman (Figure 9-5 and Table 9-2).

Electrocardiography

Echocardiogram

image

*Decrease or normalize with deep inspiration.

From Gei, A.F. & Hankins, G.D. (2001). Cardiac disease and pregnancy. Obstet Gynecol Clin North Am, 28, 473.

The heart and blood vessels undergo remodeling during pregnancy.68,158 All four chambers enlarge, with the greatest change seen in the left atrium.68 Cardiac ventricular wall muscle mass increases by 10% to 15% in the first trimester; end-diastolic volume increases in the second and third trimesters.27,111,158 These changes increase cardiac compliance, augmenting stroke volume and maintaining the ejection fraction.27,111,158 Increases in left atrial diameter parallel increases in blood volume, beginning in the first trimester and peaking around 30 weeks.111 Thus the pregnant woman has a physiologically dilated heart with increased compliance.111,158

The exact mechanism underlying changes in blood vessels is also unclear, but the result is an increase in aortic size, aortic compliance (evident by 5 weeks postmenstrual age), venous blood volume, and venous compliance.111,158

Buy Membership for Neonatal and Perinatal Medicine Category to continue reading. Learn more here